РЕИМЕКС ФАРМА ООД
A United Kingdom supplier, with 8 awarded contracts, totalling £6.8m, most recently 4 months ago.
This contract is for the supply of pharmaceutical products, specifically Fenfluramine, an oral solution at a concentration of 2.2mg/ml in 120ml bottles. The awarded supplier, Reimex Pharma Ltd., is required to deliver 9 packages of this product as per the request from the University Multi-Profiling
This contract involves the supply of pharmaceutical products, specifically the drug Odevixibat, which is listed under Article 266a, paragraph 2 of the Law on Medicinal Products for Human Use in Bulgaria. The buyer is the University Multi-Profile Hospital for Active Treatment 'St. George' EAD. Suppli
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) 'Electrolytes', which includes various salts in combination. The product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products in Human Medicine. The total va
This contract involves the supply of the pharmaceutical product Odevixibat, with an active ingredient of 1200 micrograms. The product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The buyer is the Specialized Hospital for Active Treatment of Children's Disease
This contract involves the delivery of the pharmaceutical product Koselugo, 10 mg, manufactured by AstraZeneca. The supplier is required to provide four packages, each containing sixty capsules. The total value of the contract is approximately €51,667. This opportunity is part of the health sector a
This contract involves the supply of pharmaceutical products, specifically Maralixibat chloride, which is listed under Article 266a, paragraph 2 of the Law on Medicinal Products for Human Use. The total value of the contract is approximately €198,892.68. The buyer is the University Multi-Profile Hos
This contract involves the delivery of pharmaceutical products, specifically Ravulizumab, which are included in the list under Article 266a, paragraph 2 of the Law on Medicinal Products for Human Use. The buyer is the University Multi-Profile Hospital for Active Treatment 'St. George' EAD, and the a
This contract involves the supply of pharmaceutical products, specifically Fluorescein, which is listed under Article 266a, paragraph 2 of the Law on Medicinal Products for Human Use. The buyer is the University Multi-Profile Hospital for Active Treatment 'St. George' EAD, and the total value of the
